Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

Oncogene

Volumn 27, Issue 42, 2008, Pages 5643-5647

  Bhaumik, D ^a   Scott, G K ^a   Schokrpur, S ^a   Patil, C K ^b   Campisi, J ^a,b   Benz, C C ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Metastatic breast cancer; miRNA 146; NF B

Indexed keywords

DNA; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 146; MICRORNA 146 A; MICRORNA 146 B; SCAFFOLD PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ACTIVITY; DNA BINDING; ENZYME PHOSPHORYLATION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; INTERLEUKIN-8; MICRORNAS; NEOPLASM METASTASIS; NF-KAPPA B;

EID: 52149102044     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.171     Document Type: Article

References (26)

1. Akira S, Takeda K. (2004). Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
2. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S et al. (2004). Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10: 7157-7162.
4. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D et al. (2004). Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23: 4202-4210.
5. Cao Z, Henzel WJ, Gao X. (1996a). IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128-1131.
6. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. (1996b). TRAF6 is a signal transducer for interleukin-1. Nature 383: 443-446.
7. Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. (2005). Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 65: 3586-3595.
8. Coppe JP, Kauser K, Campisi J, Beausejour CM. (2006). Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 281: 29568-29574.
9. Hayden MS, Ghosh S. (2004). Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
10. Hoffmann A, Baltimore D. (2006). Circuitry of nuclear factor kappaB signaling. Immunol Rev 210: 171-186.
11. Karin M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
12. Karres JS, Hilgers V, Carrera I, Treisman J, Cohen SM. (2007). The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 131: 136-145.
13. Lin SL, Chiang A, Chang D, Ying SY. (2008). Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14: 417-424.
14. Ma L, Teruya-Feldstein J, Weinberg RA. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
15. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E et al. (2006). Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4: 437-447.
16. Monks NR, Pardee AB. (2006). Targeting the NF-kappaB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem 98: 221-233.
17. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. (2007). Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282: 1479-1486.
18. Sethi G, Sung B, Aggarwal BB. (2008). Nuclear factor-{kappa}B activation: from bench to bedside. Exp Biol Med 233: 21-31.
19. Singer CF, Kronsteiner N, Hudelist G, Marton E, Walter I, Kubista M et al. (2003). Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res 9: 4877-4883.
20. Sliva D, Rizzo MT, English D. (2002). Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 277: 3150-3157.
21. Sonkoly E, Stahle M, Pivarcsi A. (2008). MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-140.
22. Taganov KD, Boldin MP, Baltimore D. (2007). MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137.
23. Taganov KD, Boldin MP, Chang KJ, Baltimore D. (2006). NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486.
24. Van Waes C. (2007). Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082.
25. Zheng Y, Rodrik V, Toschi A, Shi M, Hui L, Shen Y et al. (2006). Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem 281: 15862-15868.
26. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC. (2005). The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12(Suppl 1): S37-S46.